The Food and Drug Administration approved a drug to prevent the transmission of HIV on Monday, the New York Daily News said.
The drug, called Truvada, is manufactured by Gilead Sciences of California, the New York Daily News said.
Truvada has been on the market since 2004 for teens and adults with HIV combined with other antiretroviral drugs, CBS News said.
The new approval from the FDA allows the drug to be used by healthy teens and adults, in combination with safe sex practices, to prevent HIV, CBS News said.
Studies have found Truvada to cut the risk of HIV in healthy gay and bisexual men by 42 percent and by 72 percent in heterosexual individuals who have an HIV infected partner, CBS News said.